Carlos Munoz-Neira
Overview
Explore the profile of Carlos Munoz-Neira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munoz-Neira C, Zeng J, Kucikova L, Huang W, Xiong X, Muniz-Terrera G, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274441
: The pathophysiology of Alzheimer's disease (AD) may begin developing years or even decades prior to the manifestation of its first symptoms. The APOE ε4 genotype is a prominent genetic...
2.
Isotalus H, Carr W, Blackman J, Averill G, Radtke O, Selwood J, et al.
Front Behav Neurosci
. 2024 Sep;
18:1478382.
PMID: 39262405
[This corrects the article DOI: 10.3389/fnbeh.2023.1096720.].
3.
Borchert R, Azevedo T, Badhwar A, Bernal J, Betts M, Bruffaerts R, et al.
Alzheimers Dement
. 2023 Aug;
19(12):5885-5904.
PMID: 37563912
Introduction: Artificial intelligence (AI) and neuroimaging offer new opportunities for diagnosis and prognosis of dementia. Methods: We systematically reviewed studies reporting AI for neuroimaging in diagnosis and/or prognosis of cognitive...
4.
Kucikova L, Zeng J, Munoz-Neira C, Muniz-Terrera G, Huang W, Gregory S, et al.
J Neurol
. 2023 Jun;
270(10):4949-4958.
PMID: 37358635
Background: Past evidence shows that changes in functional brain connectivity in multiple resting-state networks occur in cognitively healthy individuals who have non-modifiable risk factors for Alzheimer's Disease. Here, we aimed...
5.
Isotalus H, Carr W, Blackman J, Averill G, Radtke O, Selwood J, et al.
Front Behav Neurosci
. 2023 Apr;
17:1096720.
PMID: 37091594
Introduction: Millions of people worldwide take medications such as L-DOPA that increase dopamine to treat Parkinson's disease. Yet, we do not fully understand how L-DOPA affects sleep and memory. Our...
6.
Musa G, Slachevsky A, Munoz-Neira C, Mendez-Orellana C, Villagra R, Gonzalez-Billault C, et al.
J Alzheimers Dis
. 2019 Dec;
73(3):833-848.
PMID: 31884475
Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the most common neurodegenerative early-onset dementias. Despite the fact that both conditions have a very distinctive clinical pattern, they present with an...
7.
Munoz-Neira C, Tedde A, Coulthard E, Thai N, Pennington C
Neuroimage Clin
. 2019 Dec;
24:102066.
PMID: 31795052
Altered insight into disease or specific symptoms is a prominent clinical feature of frontotemporal dementia (FTD). Understanding the neural bases of insight is crucial to help improve FTD diagnosis, classification...
8.
Slachevsky A, Forno G, Barraza P, Mioshi E, Delgado C, Lillo P, et al.
J Neurol
. 2019 Apr;
266(6):1310-1322.
PMID: 30949817
Background: Impairments in activities of daily living (ADL) are a criterion for Alzheimer's disease (AD) dementia. However, ADL gradually decline in AD, impacting on advanced (a-ADL, complex interpersonal or social...
9.
Slachevsky A, Barraza P, Hornberger M, Munoz-Neira C, Flanagan E, Henriquez F, et al.
J Alzheimers Dis
. 2017 Dec;
61(2):589-600.
PMID: 29226861
Episodic memory tests with cued recall, such as the Free and Cued Selective Reminding Test (FCSRT), allow for the delineation of hippocampal and prefrontal atrophy contributions to memory performance in...
10.
Jory J, Bruna A, Munoz-Neira C, Slachevsky Chonchol A
Dement Neuropsychol
. 2017 Dec;
7(1):40-47.
PMID: 29213818
Objective: This study sought to analyze the psychometric properties and diagnostic accuracy of the Chilean version of the INECO Frontal Screening (IFS-Ch) in a sample of dementia patients and control...